NCT07236606Phase 3Active not recruiting

RGX-121-3102 Gene Therapy in Participants With MPS II (Hunter Syndrome)

Study sponsor: REGENXBIO Inc. · RGNX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2028-04-30Estimated
Enrollment · participants2Estimated
Source updated2026-06-04Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Suspended. After: Active not recruiting.

Check registry source

· 1 field changed

Recruitment status changed

Before: Recruiting. After: Suspended.

Check registry source

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source